A Randomized Open-Label Clinical Trial of Lipid-Lowering Therapy in Psoriasis to Reduce Vascular Endothelial Inflammation. Academic Article uri icon

Overview

publication date

  • November 19, 2021

Research

keywords

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Psoriasis

Identity

PubMed Central ID

  • PMC9893130

Scopus Document Identifier

  • 85123364970

Digital Object Identifier (DOI)

  • 10.1016/j.jid.2021.07.190

PubMed ID

  • 34808233

Additional Document Info

volume

  • 142

issue

  • 6